Approval · Notice of Compliance 858 · 2002
ZANAFLEX: Notice of Compliance 858
Issued February 19, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 858
- Date
- February 19, 2002
- Company
- Elan Pharmaceuticals, Inc.South San Francisco, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Antipastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZANAFLEX | 02245328 | — |
Medicinal ingredients
- TIZANIDINE HCL 2 MG per TAB